Cynosure Group LLC lifted its holdings in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 77.5% in the third quarter, HoldingsChannel reports. The institutional investor owned 6,987 shares of the business services provider’s stock after buying an additional 3,050 shares during the period. Cynosure Group LLC’s holdings in Exponent were worth $805,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the stock. Quarry LP bought a new stake in Exponent in the second quarter valued at approximately $25,000. GAMMA Investing LLC grew its position in Exponent by 67.7% during the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock worth $36,000 after buying an additional 153 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in shares of Exponent by 166.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 517 shares of the business services provider’s stock worth $49,000 after purchasing an additional 323 shares during the period. USA Financial Formulas acquired a new stake in Exponent during the third quarter worth about $60,000. Finally, Benjamin F. Edwards & Company Inc. raised its position in shares of Exponent by 70.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 873 shares of the business services provider’s stock valued at $83,000 after buying an additional 361 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.
Exponent Trading Down 1.3 %
NASDAQ EXPO opened at $98.99 on Wednesday. The firm’s 50 day simple moving average is $106.17 and its 200 day simple moving average is $102.22. The firm has a market capitalization of $5.02 billion, a price-to-earnings ratio of 47.82 and a beta of 0.69. Exponent, Inc. has a 1 year low of $68.70 and a 1 year high of $115.75.
Exponent Announces Dividend
Insider Buying and Selling
In other Exponent news, Director Paul R. Johnston sold 1,300 shares of Exponent stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total transaction of $123,539.00. Following the transaction, the director now directly owns 59,406 shares of the company’s stock, valued at approximately $5,645,352.18. The trade was a 2.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the sale, the director now owns 5,871 shares of the company’s stock, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,339 shares of company stock worth $3,103,065 in the last ninety days. 2.10% of the stock is owned by insiders.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- Are Penny Stocks a Good Fit for Your Portfolio?
- 2 Essential Data Center Solutions Providers Riding the AI Boom
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Holiday Cheer or Market Fear: Navigating the Year-End Rally
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Gold vs. Silver: Profit Opportunities in the Widening Spread
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.